TransIT®-BrCa Transfection Reagent
Superior DNA transfection of breast cancer cell typesTransIT-BrCa Transfection Reagent is the first dedicated breast cancer cell line specific reagent available to researchers today. While it delivers efficiently to many breast cancer cell types, it also maintains low cellular toxicity resulting in reduced experimental biases. TransIT®-BrCa Transfection Reagent is specifically optimized to provide exceptional transfection effi…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Superior DNA transfection of breast cancer cell types
TransIT-BrCa Transfection Reagent is the first dedicated breast cancer cell line specific reagent available to researchers today. While it delivers efficiently to many breast cancer cell types, it also maintains low cellular toxicity resulting in reduced experimental biases. TransIT®-BrCa Transfection Reagent is specifically optimized to provide exceptional transfection efficiency of plasmid DNA in breast cancer and related cell types including: MCF-7, MDA-MB-231 and T47D cells.
TransIT®-BrCa Transfection Reagent Features:
•Broad Spectrum DNA Delivery - Achieve high expression levels in breast cancer cell types including: MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468, and T47D.
•Formulated for Low Cellular Toxicity - Maintain cell density and reduce experimental biases due to toxicity.
•Superior Transfection Efficiency - TransIT®-BrCa outperforms Lipofectamine® 2000, in multiple breast cancer cell lines.
